{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:44:46Z","timestamp":1780566286965,"version":"3.54.1"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2024-0184_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Placental growth factor (PlGF) has been reported as a good biomaker for the prediction of preeclampsia occurring in the short term in singleton pregnancies, in women presenting with clinical suspicion of preeclampsia. This study aims to evaluate the predictive value of the PlGF in twin pregnancies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0184_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Twin pregnancies with clinically suspected preeclampsia (24\u00a0weeks 0\u00a0days\u201336\u00a0weeks 6\u00a0days of gestation) were enrolled in this study. The threshold of PlGF for predicting preeclampsia was determined on the basis of a receiver-operating characteristic curve to predict preeclampsia and the short-term occurrence of preeclampsia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0184_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Within 1\u00a0week, 2\u00a0weeks, and 4\u00a0weeks of testing respectively, a cutoff value of 215\u202fpg\/mL for PlGF to predict preeclamsia in twin pregnancies suspected to have preeclampsia has a specificity of 100\u202f%[51.7\u202f%, 100\u202f%], 100\u202f%[62.9\u202f%, 100\u202f%], 93.8\u202f%[667.6\u202f%, 99.7\u202f%], and a negative predictive value of 100\u202f%[94.8\u202f%, 100\u202f%], 100\u202f%[95.0\u202f%, 100\u202f%], and 98.9\u202f%[93.0\u202f%, 99.9\u202f%].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0184_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A cutoff value of 215\u202fpg\/mL for PlGF is a useful tool to exclude the development of preeclampsia within 4\u00a0weeks of measurement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2024-0184","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T17:02:45Z","timestamp":1734714165000},"page":"149-157","source":"Crossref","is-referenced-by-count":2,"title":["Placental growth factor as a predictive marker of preeclampsia in twin pregnancy"],"prefix":"10.1515","volume":"53","author":[{"given":"Guijie","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanru","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory , The Hospital of Maternal and Health of Tangshan , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Genetics , Tangshan Maternal and Children Health Hospital , Tangshan City , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"2025031312391156849_j_jpm-2024-0184_ref_001","doi-asserted-by":"crossref","unstructured":"Ananth, CV, Keyes, KM, Wapner, RJ. Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis. BMJ 2013;347:f6564. https:\/\/doi.org\/10.1136\/bmj.f6564.","DOI":"10.1136\/bmj.f6564"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_002","doi-asserted-by":"crossref","unstructured":"Duley, L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010.","DOI":"10.1053\/j.semperi.2009.02.010"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_003","doi-asserted-by":"crossref","unstructured":"Magee, LA, Brown, MA, Hall, DR, Gupte, S, Hennessy, A, Karumanchi, SA, et al.. The 2021 International society for the study of hypertension in pregnancyclassification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2022;27:148. https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008.","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_004","doi-asserted-by":"crossref","unstructured":"Wiles, K, Chappell, LC, Lightstone, L, Bramham, K. Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol 2020;15:1371\u201380. https:\/\/doi.org\/10.2215\/cjn.15121219.","DOI":"10.2215\/CJN.15121219"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_005","doi-asserted-by":"crossref","unstructured":"Torry, DS, Wang, HS, Wang, TH, Caudle, MR, Torry, RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539\u201344. https:\/\/doi.org\/10.1016\/s0002-9378(98)70021-3.","DOI":"10.1016\/S0002-9378(98)70021-3"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_006","doi-asserted-by":"crossref","unstructured":"Levine, RJ, Maynard, SE, Qian, C, Lim, KH, England, LJ, Schisterman, EF, et al.. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672\u201383. https:\/\/doi.org\/10.1056\/nejmoa031884.","DOI":"10.1056\/NEJMoa031884"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_007","doi-asserted-by":"crossref","unstructured":"Chappell, LC, Duckworth, S, Seed, PT, Griffin, M, Myers, J, Mackillop, L, et al.. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013;128:2121\u201331. https:\/\/doi.org\/10.1161\/circulationaha.113.003215.","DOI":"10.1161\/CIRCULATIONAHA.113.003215"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_008","doi-asserted-by":"crossref","unstructured":"Duhig, KE, Myers, J, Seed, PT, Sparkers, J, Lowe, J, Hunter, RM, et al.. Placental growth factor testing to assess women with suspectedpre-eclampsia: a multicentre, pragmatic, stepped-wedge\u00a0cluster-randomised controlled trial. Lancet 2019;393:1807\u201318. https:\/\/doi.org\/10.1016\/s0140-6736(18)33212-4.","DOI":"10.1016\/S0140-6736(18)33212-4"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_009","doi-asserted-by":"crossref","unstructured":"Duhig, KE, Webster, LM, Sharp, A, Gill, C, Seed, PT, Shennan, AH, et al.. Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: a case series study. Acta Obstet Gynecol Scand 2020;99:994\u20131002. https:\/\/doi.org\/10.1111\/aogs.13818.","DOI":"10.1111\/aogs.13818"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_010","unstructured":"Kaaja, R. Predictors and risk factors of pre-eclampsia. Minerva Ginecol 2008;60:421\u20139."},{"key":"2025031312391156849_j_jpm-2024-0184_ref_011","doi-asserted-by":"crossref","unstructured":"Laine, K, Murzakanova, G, Sole, KB, Pay, AD, Heradstveit, S, Raisanen, S. Prevalence and risk of pre-eclampsia and gestational hypertension in twin pregnancies: a population-based register study. BMJ Open 2019;9:e029908. https:\/\/doi.org\/10.1136\/bmjopen-2019-029908.","DOI":"10.1136\/bmjopen-2019-029908"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_012","doi-asserted-by":"crossref","unstructured":"Brown, MA, Magee, LA, Kenny, LC, Karumanchi, SA, McCarthy, FP, Saito, S, International Society for the Study of Hypertension in Pregnancy (ISSHP), et al.. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for\u00a0international practice. Pregnancy Hypertens 2018;13:291\u2013310. https:\/\/doi.org\/10.1016\/j.preghy.2018.05.004.","DOI":"10.1016\/j.preghy.2018.05.004"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_013","doi-asserted-by":"crossref","unstructured":"Tan, MY, Syngelaki, A, Poon, LC, Rolnik, DL, O\u2019Gorman, N, Delgado, JL, et al.. Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313\u00a0weeks\u2019 gestation. Ultrasound Obstet Gynecol 2018;52:186\u201395. https:\/\/doi.org\/10.1002\/uog.19112.","DOI":"10.1002\/uog.19112"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_014","doi-asserted-by":"crossref","unstructured":"Rana, S, Hacker, MR, Modest, AM, Salahuddin, S, Lim, KH, Verlohren, S, et al.. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected pre-eclampsia. Hypertension 2012;60:451\u20138. https:\/\/doi.org\/10.1161\/hypertensionaha.112.195065.","DOI":"10.1161\/HYPERTENSIONAHA.112.195065"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_015","doi-asserted-by":"crossref","unstructured":"Dr\u00f6ge, L, Herra\u00ecz, I, Zeisler, H, Schlembach, D, Stepan, H, K\u00fcssel, L, et al.. Maternal serum sFLT1\/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Ultrasound Obs. Gynecol. 2015;45:286\u201393. https:\/\/doi.org\/10.1002\/uog.14760.","DOI":"10.1002\/uog.14760"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_016","doi-asserted-by":"crossref","unstructured":"Shinohara, S, Sunami, R, Kasai, M, Yasuda, G, Uchida, Y. Predictive\u00a0value\u00a0of\u00a0the sFLT1\/PlGF ratio for pre-eclampsia in twin pregnancies:\u00a0a\u00a0retrospective study. Hypertens Pregnancy 2021;40:330\u20135. https:\/\/doi.org\/10.1080\/10641955.2021.1987455.","DOI":"10.1080\/10641955.2021.1987455"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_017","doi-asserted-by":"crossref","unstructured":"O\u2019Gorman, N, Wright, D, Poon, LC, Rolnik, DL, Syngelaki, A, de Alvarado, M, et al.. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13\u00a0weeks\u2019gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol 2017;49:756\u201360.","DOI":"10.1002\/uog.17455"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_018","doi-asserted-by":"crossref","unstructured":"Gallo, DM, Wright, D, Casanova, C, Campanero, M, Nicolaides, KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24\u00a0weeks\u2019 gestation. Am J Obstet Gynecol 2016;214:619.e1\u2013e17. https:\/\/doi.org\/10.1016\/j.ajog.2015.11.016.","DOI":"10.1016\/j.ajog.2015.11.016"},{"key":"2025031312391156849_j_jpm-2024-0184_ref_019","doi-asserted-by":"crossref","unstructured":"Tsiakkas, A, Saiid, Y, Wright, A, Wright, D, Nicolaides, KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34\u00a0weeks\u2019 gestation. Am J Obstet Gynecol 2016;215:87.e1\u2013e17. https:\/\/doi.org\/10.1016\/j.ajog.2016.02.016.","DOI":"10.1016\/j.ajog.2016.02.016"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2024-0184\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2024-0184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:46:13Z","timestamp":1741869973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2024-0184\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,23]]},"published-print":{"date-parts":[[2025,2,25]]}},"alternative-id":["10.1515\/jpm-2024-0184"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0184","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}